Metraipolis › archive › dc_6d56320dbd71
Real-World Investigation of Satralizumab in Patients With Neuromyelitis Optica Spectrum Disease — Europe PMC PMID:41236176
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41236176
- DOI
- 10.1002/acn3.70246
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-08T13:52:32.890Z
- SHA-256 of the archived text
4c7122d7fa7154f84b8b964f1a3fcfd4d2a25e0a12b6b064c87a57bfdfba48b0- Stable URL of this page
https://metraipolis.com/documento/dc_6d56320dbd71
How to cite
Real-World Investigation of Satralizumab in Patients With Neuromyelitis Optica Spectrum Disease — Europe PMC PMID:41236176 — Europe PMC (en), https://europepmc.org/article/MED/41236176 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_6d56320dbd71 (Metraipolis archive dc_6d56320dbd71, sha256 4c7122d7fa7154f84b8b964f1a3fcfd4d2a25e0a12b6b064c87a57bfdfba48b0)
BibTeX
@misc{dc6d56320dbd71,
title = {Real-World Investigation of Satralizumab in Patients With Neuromyelitis Optica Spectrum Disease — Europe PMC PMID:41236176},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41236176},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_6d56320dbd71; sha256 4c7122d7fa7154f84b8b964f1a3fcfd4d2a25e0a12b6b064c87a57bfdfba48b0},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41236176. Agents can read the archived copy with the MCP tool read_document.